Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 4 |
2012 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
AE37: a novel T-cell-eliciting vaccine for breast cancer.
Expert Opin Biol Ther. 2011 Nov;11(11):1543-50. doi: 10.1517/14712598.2011.616889. Epub 2011 Sep 6.
Expert Opin Biol Ther. 2011.
PMID: 21895539
Review.
Folate receptor α: a storied past and promising future in immunotherapy.
Clifton GT, Sears AK, Clive KS, Holmes JP, Mittendorf EA, Ioannides CG, Ponniah S, Peoples GE.
Clifton GT, et al. Among authors: sears ak.
Hum Vaccin. 2011 Feb;7(2):183-90. doi: 10.4161/hv.7.2.13784. Epub 2011 Feb 1.
Hum Vaccin. 2011.
PMID: 21321484
Review.
Item in Clipboard
Comparison of different HER2/neu vaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines.
Benavides LC, Sears AK, Gates JD, Clifton GT, Clive KS, Carmichael MG, Holmes JP, Mittendorf EA, Ponniah S, Peoples GE.
Benavides LC, et al. Among authors: sears ak.
Expert Rev Vaccines. 2011 Feb;10(2):201-10. doi: 10.1586/erv.10.167.
Expert Rev Vaccines. 2011.
PMID: 21332269
Review.
Item in Clipboard
Cancer vaccines: should we be targeting patients with less aggressive disease?
Hale DF, Clifton GT, Sears AK, Vreeland TJ, Shumway N, Peoples GE, Mittendorf EA.
Hale DF, et al. Among authors: sears ak.
Expert Rev Vaccines. 2012 Jun;11(6):721-31. doi: 10.1586/erv.12.39.
Expert Rev Vaccines. 2012.
PMID: 22873128
Review.
Item in Clipboard
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide.
Gates JD, Clifton GT, Benavides LC, Sears AK, Carmichael MG, Hueman MT, Holmes JP, Jama YH, Mursal M, Zacharia A, Ciano K, Khoo S, Stojadinovic A, Ponniah S, Peoples GE.
Gates JD, et al. Among authors: sears ak.
Vaccine. 2010 Nov 3;28(47):7476-82. doi: 10.1016/j.vaccine.2010.09.029. Epub 2010 Sep 19.
Vaccine. 2010.
PMID: 20858449
Clinical Trial.
Item in Clipboard
Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Mittendorf EA, Clifton GT, Holmes JP, Clive KS, Patil R, Benavides LC, Gates JD, Sears AK, Stojadinovic A, Ponniah S, Peoples GE.
Mittendorf EA, et al. Among authors: sears ak.
Cancer. 2012 May 15;118(10):2594-602. doi: 10.1002/cncr.26574. Epub 2011 Oct 11.
Cancer. 2012.
PMID: 21989902
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite